Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C095284 |
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one |
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Carbon Monoxide results in increased expression of TFAM protein] | decreases reaction|increases expression | 17179207
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of TFAM mRNA | affects expression | 21346803
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide results in increased expression of TFAM protein] | decreases reaction|increases expression | 17179207
|
C005975 |
3,4-dihydroxyphenylethanol |
3,4-dihydroxyphenylethanol inhibits the reaction [Acrolein results in decreased expression of TFAM mRNA] | decreases expression|decreases reaction | 20938484
|
C516138 |
(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine |
(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in increased expression of TFAM mRNA] | decreases reaction|increases expression | 17438283
|
D000171 |
Acrolein |
3,4-dihydroxyphenylethanol inhibits the reaction [Acrolein results in decreased expression of TFAM mRNA] | decreases expression|decreases reaction | 20938484
|
D000171 |
Acrolein |
Acrolein results in decreased expression of TFAM mRNA | decreases expression | 20938484
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of TFAM mRNA | affects expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of TFAM mRNA | increases expression | 19150397
|
C459604 |
candoxin |
candoxin results in decreased expression of TFAM mRNA | decreases expression | 16309724
|
D002248 |
Carbon Monoxide |
Carbon Monoxide results in increased expression of TFAM mRNA | increases expression | 17179207
|
D002248 |
Carbon Monoxide |
Carbon Monoxide results in increased expression of TFAM protein | increases expression | 17179207
|
D002248 |
Carbon Monoxide |
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Carbon Monoxide results in increased expression of TFAM protein] | decreases reaction|increases expression | 17179207
|
D002248 |
Carbon Monoxide |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide results in increased expression of TFAM protein] | decreases reaction|increases expression | 17179207
|
D002248 |
Carbon Monoxide |
Carbon Monoxide promotes the reaction [GABPA protein binds to TFAM promoter] | affects binding|increases reaction | 17179207
|
D002248 |
Carbon Monoxide |
Carbon Monoxide promotes the reaction [NRF1 protein binds to TFAM promoter] | affects binding|increases reaction | 17179207
|
D002248 |
Carbon Monoxide |
Carbon Monoxide results in increased expression of TFAM protein | increases expression | 17179207
|
D002248 |
Carbon Monoxide |
CAT protein inhibits the reaction [Carbon Monoxide promotes the reaction [NRF1 protein binds to TFAM promoter]] | affects binding|decreases reaction|increases reaction | 17179207
|
D002976 |
Clenbuterol |
Clenbuterol results in increased expression of TFAM mRNA | increases expression | 17446185
|
D016047 |
Zalcitabine |
Zalcitabine affects the expression of TFAM protein | affects expression | 7849699
|
D004610 |
Ellagic Acid |
Ellagic Acid results in decreased expression of TFAM mRNA | decreases expression | 12002526
|
D004958 |
Estradiol |
[Estradiol co-treated with Norepinephrine] results in decreased expression of TFAM mRNA | affects cotreatment|decreases expression | 16954335
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of TFAM mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of TFAM mRNA | increases expression | 17942748
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of TFAM mRNA | increases expression | 18035473
|
D005632 |
Fructose |
Fructose results in increased expression of TFAM protein | increases expression | 11934685
|
D017313 |
Fenretinide |
Fenretinide affects the expression of TFAM mRNA | affects expression | 16570282
|
C006552 |
kaempferol |
kaempferol results in increased expression of TFAM mRNA | increases expression | 17327447
|
D009638 |
Norepinephrine |
[Estradiol co-treated with Norepinephrine] results in decreased expression of TFAM mRNA | affects cotreatment|decreases expression | 16954335
|
D009638 |
Norepinephrine |
[Progesterone co-treated with Norepinephrine] results in increased expression of TFAM mRNA | affects cotreatment|increases expression | 16954335
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of TFAM mRNA | increases expression | 18301758
|
D011374 |
Progesterone |
[Progesterone co-treated with Norepinephrine] results in increased expression of TFAM mRNA | affects cotreatment|increases expression | 16954335
|
D011374 |
Progesterone |
Progesterone results in increased expression of TFAM mRNA | increases expression | 16954335
|
C059514 |
resveratrol |
resveratrol results in decreased expression of TFAM mRNA | decreases expression | 12002526
|
C059514 |
resveratrol |
(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in increased expression of TFAM mRNA] | decreases reaction|increases expression | 17438283
|
C059514 |
resveratrol |
resveratrol results in increased expression of TFAM mRNA | increases expression | 17438283
|
D012643 |
Selenium |
NRF1 protein promotes the reaction [Selenium results in increased expression of TFAM mRNA] | increases expression|increases reaction | 17936198
|
D012643 |
Selenium |
Selenium results in increased expression of TFAM mRNA | increases expression | 17936198
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of TFAM mRNA | increases expression | 12016162
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of TFAM mRNA | decreases expression | 17101203
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TFAM mRNA | increases expression | 16960034
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TFAM mRNA | increases expression | 16960034
|
D014501 |
Uranium |
Uranium affects the expression of TFAM mRNA | affects expression | 15672453
|
C005460 |
uranyl acetate |
uranyl acetate affects the expression of TFAM mRNA | affects expression | 15672453
|
D015215 |
Zidovudine |
Zidovudine results in increased expression of TFAM mRNA | increases expression | 10535663
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.59 | 11752688 14514962 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.30 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.68 | 17505938 |
MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
4.57 | 9612607 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.62 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Acrolein |
8.48 | 21297076 20525806 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.48 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
6.74 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
6.74 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
6.74 | 10697514 |
MESH:D000236 |
Adenoma |
|
resveratrol |
3.17 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.02 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.02 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.43 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.64 | 17306315 16712894 |
MESH:D000544 |
Alzheimer Disease |
marker/mechanism |
|
| 17192785 |
MESH:D000544 |
Alzheimer Disease |
|
Acrolein |
4.48 | 17570602 14715435 15207723 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
4.48 | 16162502 16183991 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.72 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Acrolein |
9.46 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
9.46 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.83 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
6.83 | 17115116 |
MESH:D050197 |
Atherosclerosis |
|
Acrolein |
6.64 | 17363696 16037261 16126721 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
6.64 | 17967414 16873680 |
MESH:D001321 |
Autistic Disorder |
|
Norepinephrine |
3.39 | 8570775 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.99 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.99 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.52 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.60 | 15746008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.07 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.00 | 15665606 15380490 15845082 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.02 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
4.13 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.84 | 17261762 17018787 16675129 17289903 14630087 19861407 12948864 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
2.84 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
kaempferol |
2.84 | 16756079 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.84 | 17614352 16175315 15562024 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.84 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.84 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.20 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.59 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
8.41 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
8.41 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
8.41 | 17159502 16270382 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
8.41 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
8.41 | 15276417 17306315 16507464 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.33 | 16675471 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
7.25 | 16274795 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
7.25 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.25 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Norepinephrine |
6.71 | 11179087 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.71 | 16120746 18850075 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Zalcitabine |
4.54 | 10591146 |
MESH:D002318 |
Cardiovascular Diseases |
|
kaempferol |
7.32 | 16756079 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
7.32 | 15458977 |
MESH:D002375 |
Catalepsy |
|
Norepinephrine |
5.27 | 8216760 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.16 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
10.16 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
10.16 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
5.21 | 16154183 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.94 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.10 | 11677210 17681005 16105132 17110522 15861022 17333356 16919318 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.10 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.99 | 16354765 12621046 8697196 15340226 15668235 |
MESH:D003092 |
Colitis |
|
Carbon Monoxide |
14.81 | 16365149 |
MESH:D003092 |
Colitis |
|
resveratrol |
14.81 | 16474422 |
MESH:D003092 |
Colitis |
|
Selenium |
14.81 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
2.41 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Acrolein |
3.58 | 17597105 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
3.58 | 17273769 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
3.58 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.84 | 14669216 17141729 |
MESH:D003327 |
Coronary Disease |
|
Fructose |
8.23 | 18504504 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
8.23 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.24 | 20055451 15322242 10048152 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.76 | 18551238 |
MESH:D003556 |
Cystitis |
|
Acrolein |
5.13 | 12161096 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.30 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Fructose |
8.13 | 18603373 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
8.13 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Fructose |
4.43 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.43 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
8.29 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
8.29 | 16286809 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.23 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
5.72 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
5.72 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.72 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
12.84 | 11462148 |
MESH:D004362 |
Drug Toxicity |
|
Zalcitabine |
12.84 | 7515130 |
MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
12.84 | 15040536 |
MESH:D004487 |
Edema |
|
pirinixic acid |
10.08 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
10.08 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.08 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.64 | 16714409 18230668 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
13.93 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
13.93 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
13.93 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.81 | 18566989 11473722 19148513 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.17 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.17 | 10568697 9294722 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.59 | 17923197 |
MESH:D004827 |
Epilepsy |
|
Norepinephrine |
4.16 | 821787 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.01 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.82 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
22.20 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Fructose |
22.20 | 19196556 18395287 18641190 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
22.20 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Zalcitabine |
22.20 | 18299183 |
MESH:D005234 |
Fatty Liver |
|
Zidovudine |
22.20 | 18299183 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.20 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Fructose |
8.18 | 18504504 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.18 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.42 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
3.72 | 16187019 |
MESH:D018149 |
Glucose Intolerance |
|
Fructose |
5.08 | 19165636 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.33 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.19 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.42 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
6.42 | 17162251 |
MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
4.47 | 12579204 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.10 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.41 | 19772884 18467677 19176532 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.41 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.76 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.92 | 16876885 |
MESH:D015658 |
HIV Infections |
|
Zalcitabine |
6.81 | 17457083 |
MESH:D015658 |
HIV Infections |
|
Zidovudine |
6.81 | 11363243 11141242 11698656 17358032 20032539 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.94 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.49 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.78 | 16959395 18606429 15340226 8697196 16354765 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.77 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
kaempferol |
8.84 | 18262572 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
8.84 | 20558911 |
MESH:D006946 |
Hyperinsulinism |
|
Fructose |
4.68 | 14757778 18563319 15752949 19008412 18360027 |
MESH:D006949 |
Hyperlipidemias |
|
Fructose |
8.90 | 15752949 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
8.90 | 16873680 |
MESH:D006973 |
Hypertension |
|
Fructose |
5.17 | 16843071 14573337 14568997 14633139 19008412 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.17 | 18850075 18670907 |
MESH:D015228 |
Hypertriglyceridemia |
|
Fructose |
4.85 | 19342510 19799862 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.07 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.55 | 16945680 16569931 |
MESH:D007022 |
Hypotension |
|
Norepinephrine |
4.75 | 6740701 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
10.63 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
10.63 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.22 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.07 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.07 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
10.86 | 17296493 |
MESH:D007249 |
Inflammation |
|
Progesterone |
10.86 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
10.86 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
10.86 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
10.19 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
10.19 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
11.46 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
Fructose |
11.46 | 18563319 19799862 19008412 14757778 14633139 18057795 18981581 19342510 14573337 17133782 19586609 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
11.46 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.10 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Acrolein |
9.38 | 12488133 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.38 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
9.38 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.65 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
11.28 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.28 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
11.28 | 12579204 |
MESH:D007938 |
Leukemia |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
6.76 | 12970779 |
MESH:D007938 |
Leukemia |
|
kaempferol |
6.76 | 17468513 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
4.18 | 20370541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.41 | 16087638 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
5.78 | 16707609 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.19 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.19 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.19 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Monoxide |
4.02 | 17173083 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
9.86 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
9.86 | 19812893 20405173 19073162 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
9.86 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
9.86 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
1.95 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Acrolein |
7.24 | 11504702 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.24 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.31 | 15276417 17306315 17077188 16712894 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.31 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
3.31 | 18800350 |
MESH:D008223 |
Lymphoma |
|
Zalcitabine |
4.46 | 17941976 8764131 11980663 8840982 9205081 18798262 9488045 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.06 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.66 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.98 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
17.06 | 11408345 11807958 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
17.06 | 10697514 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
17.06 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
17.06 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
17.06 | 15318939 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.22 | 19453300 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
4.99 | 16270382 |
MESH:D008545 |
Melanoma |
|
resveratrol |
4.99 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
4.99 | 16487513 19082730 |
MESH:D008546 |
Melanoma, Experimental |
|
Acrolein |
4.95 | 10803710 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.69 | 15107826 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.14 | 17112576 |
MESH:D024821 |
Metabolic Syndrome X |
|
Fructose |
4.60 | 19165636 17098227 17261469 18497449 16815490 |
MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
5.57 | 17358032 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
4.12 | 16274795 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.28 | 17049120 16490592 17935668 17164350 14749477 16267019 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.61 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.25 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.37 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
5.37 | 17188708 16317513 16525036 17015251 16456233 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.33 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.33 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
13.18 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Norepinephrine |
13.18 | 15642760 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
13.18 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.50 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.60 | 18551238 |
MESH:D009369 |
Neoplasms |
|
Acrolein |
10.87 | 17329238 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
10.87 | 17353921 15958647 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
10.87 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
10.87 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
14.00 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
14.00 | 20056578 |
MESH:D009374 |
Neoplasms, Experimental |
|
Zalcitabine |
14.00 | 9488045 9205081 8764131 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.47 | 17289903 |
MESH:D009393 |
Nephritis |
|
Acrolein |
6.02 | 12653641 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.63 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.63 | 14600291 |
MESH:D009437 |
Neuralgia |
|
Zalcitabine |
6.05 | 17292584 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
2.97 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acrolein |
8.25 | 11342003 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
8.25 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.16 | 17929310 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.41 | 16303764 |
MESH:D009765 |
Obesity |
|
Fructose |
4.62 | 17707055 18585860 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.62 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.20 | 12819281 16049721 |
MESH:D010024 |
Osteoporosis |
|
kaempferol |
4.19 | 16756079 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.01 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
14.09 | 16211241 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
14.09 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
14.09 | 16133793 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
14.09 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
14.09 | 15276417 17306315 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
3.26 | 15580305 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.44 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
Acrolein |
3.49 | 17690948 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.98 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Zalcitabine |
5.05 | 18606552 |
MESH:D010787 |
Photosensitivity Disorders |
|
Acrolein |
5.47 | 11550810 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.62 | 15087411 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.31 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
8.72 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.72 | 11222880 11399792 11896295 11118676 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.65 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.18 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
2.18 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.18 | 17675339 17804756 16731767 17718901 15767336 17636462 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.18 | 16039940 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.05 | 16919318 15861022 |
MESH:D051437 |
Renal Insufficiency |
|
Acrolein |
4.75 | 12732208 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.32 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.14 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.14 | 17058453 16314181 16317513 17520802 15827377 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.59 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
4.21 | 16303925 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.76 | 18045962 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.36 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
12.60 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
12.60 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
12.60 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.60 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.68 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.02 | 15862959 16503802 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.60 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
2.47 | 17696246 |
MESH:D020521 |
Stroke |
|
Acrolein |
4.35 | 16269634 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.25 | 16321402 |
MESH:D013610 |
Tachycardia |
|
Norepinephrine |
5.18 | 3261545 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.38 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.93 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.64 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.42 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
3.98 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
7.83 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
7.83 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
7.83 | 11723127 17306315 16452187 16712894 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.05 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
14.69 | 16154183 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
14.69 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
14.69 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
8.66 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
8.66 | 17044934 |
MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
4.50 | 12579204 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.16 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.33 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.30 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.04 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.98 | 15886252 |